Access to medicines for multiple sclerosis: Challenges and opportunities

Access to medicines for multiple sclerosis: Challenges and opportunities

Tim Wilsdon
Life Sciences | Pharmaceuticals

A recent study by Charles River Associates reveals inequities in access to treatment for multiple sclerosis (MS) across Europe. A summary of key findings, with a link to the full report, can be found at the link below.

Download PDF